DKA Knowledge Challenge!

Diabetic ketoacidosis isn’t just an emergency room concern. It can start with subtle signs you might see first in your patients. This quick quiz zeroes in on the key red flags, risk factors, and management essentials of DKA that every PCP should know. Test your knowledge and sharpen your clinical instincts - it could make all the difference.

Click here to participate in survey

Latest News

DASH4D Diet Reduces BP by 4.6 mm Hg in Adults with T2D on Maximal Antihypertensive Therapy
DASH4D Diet Reduces BP by 4.6 mm Hg in Adults with T2D on Maximal Antihypertensive Therapy

June 17th 2025

For individuals with T2D, findings are more than numeric; a 5-mm Hg reduction in SBP reduces stroke risk by 14%, CV events by 6%, and heart failure by 8%, authors wrote.

Novo Nordisk Advances Amycretin SC and Oral into Phase 3 Development for Weight Management /image credit ©Remigiusz Góra/stock.adobe.com
Novo's GLP-1/Amylin Dual Agonist Amycretin to Enter Late-Stage Trials for Obesity

June 13th 2025

GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose / image credit: ©New Africa/AdobeStock
GLP-1s May Cut Obesity-Related Cancer Risk: Daily Dose

June 13th 2025

High Discontinuation Rates of GLP-1 RA-Based Drugs Linked to Weight Loss Far Below Phase 3 Clinical Trials / image credit ©brovarky/stock.adobe.com
High Discontinuation Rates of GLP-1 RA-Based Drugs Linked to Weight Loss Far Below Phase 3 Clinical Trials

June 12th 2025

First-Ever Guideline Establishes Lifestyle Intervention as Central Strategy in Treating and Reversing Type 2 Diabetes and Prediabetes / image credit ©American College of Lifestyle Medicine
First-Ever Guideline Establishes Lifestyle Intervention as Central Strategy in Treating, Reversing Type 2 Diabetes and Prediabetes

June 11th 2025

Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.